Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C11-choline PET/MR and mpMRI for Staging High-risk Prostate Cancer
NCT03404648Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of choline C 11 in prostate adenocarcinoma, sponsored by Mayo Clinic. Started Nov 2017; status: completed.
02
Drugs
choline C 11
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT03404648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404648.